|
Report Date : |
05.07.2012 |
IDENTIFICATION DETAILS
|
Name : |
ADVANCE PHARMA CO LTD |
|
|
|
|
Registered Office : |
300CAF Canadia (St 284), |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
30.08.2006 |
|
|
|
|
Legal Form : |
Company Limited |
|
|
|
|
Line of Business : |
Not Available |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
C |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
Status : |
Undetermined |
|
|
|
|
Payment Behaviour : |
--- |
|
|
|
|
Litigation : |
--- |
NOTES :
Any query related to this report can be made on
e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Cambodia |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Details |
||
|
Organization Name |
: |
ADVANCE PHARMA CO LTD |
|
Address |
: |
300CAF Canadia (St 284), Phnom Penh |
|
Country |
: |
Cambodia |
|
Phone (S) |
: |
[+855] 23-219339 unknown. |
|
Facsimile |
: |
[+855] 23-881796 |
|
Email |
: |
avpharma@online.com.kh |
|
Primary Business Activity |
: |
Trader |
|
Key Industry |
: |
Medical Equipment & Pharmaceutical |
|
Key Facts |
|
||
|
Registered Legal Address |
: |
300CAF Canadia (St 284), Phnom Penh |
|
|
Operational Address |
: |
300CAF Canadia (St 284), Phnom Penh |
|
|
Issuing Authority |
: |
Ministry of Commerce - Commercial Registry |
|
|
License Number |
: |
9041/06P |
|
|
License Status |
: |
License exists - But no trace of any Operational office. |
|
|
Legal Form - Category |
: |
Private Company with Limited Liability |
|
|
Legal Form |
: |
Company Limited |
|
|
Legal Form - Abbreviation |
: |
CO LTD |
|
|
Operational Status of Business |
: |
It was NOT possible to confirm the operational status.(1) |
|
|
Date of Registration |
: |
30 Aug, 2006 |
|
|
Employees |
: |
|
|
|
Capital |
: |
US$ 4,880 |
|
|
Note |
: |
(1) Due
to the lack of SBE's operational status, and circumstances involved, the information
as listed below is only historical / on-file data and as such it has not been
possible to verify against any current sources. |
|
|
Report Details |
|
|||||||||||||||||||||||||||
|
COMPANY MANAGEMENT |
||||||||||||||
|
Management Listings |
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
COMPANY DIRECTORS |
||||||||||||||||||||||||
|
|
ADVERSE DATA MONITORING |
|
|
CAPITAL (Currency: KHR - Cambodia Riel) |
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
SHAREHOLDERS |
|
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
Na
Na
|
FINANCIAL STATEMENT - DETAILED |
|
Based on the corporate laws of Cambodia, legal entities
which are Private Company with Limited Liability are not required to make
public disclosure of their annual financials. Therefore no financials are
available for this entity. |
|
Today's Exchange rate |
: |
|
|
Operating Status: No trace of Subject Business Entity - Investigations indicate it has ceased business. Extensive investigations have been conducted to identify the
status of the commercial operations for the Subject Business Entity. Investigations have included: · Checks with local telecom authorities · Checks with local trade associations / organisations and B2B
Trade Portals Based on the above, it is confirmed that although the Subject
Business Entity still remains legally registered as a corporate business
entity in CAMBODIA, there is NO TRACE of the physical business operations and
as such it is believed the Subjective Business Entity has ceased operations
due to unknown reasons. |
Primary Products
|
Products / Materials / Services Description |
Activity |
|
|||||||||||
|
Pharmaceutical products |
Importing, Trading |
|
|||||||||||
|
SIC PRODUCT CLASSIFICATION & ACTIVITY |
||||||||||||
|
|
||||||||||||
|
HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY |
||||||||||||
|
|
||||||||||||
|
CORE BUSINESS DESCRIPTION |
|
Core Business |
|
The primary business focus of
ADVANCE PHARMA CO LTD is Trading - Finished products. |
|
Supplementary Business |
|
In addition to the core business, ADVANCE PHARMA CO LTD
also is engaged in the following areas of business:
|
Na
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.55 |
|
|
1 |
Rs.85.47 |
|
Euro |
1 |
Rs.68.70 |
INFORMATION DETAILS
|
Report Prepared
by : |
PDT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.